IP Library › Granted Patent US 10,801,028
Granted Patent B2
US 10,801,028 · App. 15/498,008 · Granted Oct 13, 2020

Compositions for controlling

Inventors: Ilan Sela (Ramot-HaShavim, IL); Sharoni Shafir (Nes Ziona, IL); Eyal Maori (Rishon-LeZion, IL); Yael Garbian (Rishon-LeZion, IL); Eyal Ben-Chanoch (Miami, FL); Gal Yarden (Nir-Moshe, IL); Haim Kalev (Kfar-HaNagid, IL)
Assignees: BEEOLOGICS INC.; YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
C12N15/1137A23K20/10A23K20/147A23K20/163A23K50/90A61K31/713C12N15/113C12N2310/11C12N2310/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,801,028
App. No.
15/498,008
Granted
Oct 13, 2020
Kind
B2
Abstract

An isolated nucleic acid agent is disclosed comprising a nucleic acid sequence which downregulates expression of a gene product of a Varroa destructor mite. Compositions comprising same and uses thereof are also disclosed.

Claims (18)

1. A composition comprising at least one nucleic acid agent which comprises a nucleic acid sequence which downregulates expression of a gene product of a Varroa destructor mite, and wherein said nucleic acid agent does not comprise a permeation enhancing agent selected from the group consisting of a virus, a polyamine, a polycation, a lipopolyamine, an anionic lipid, a neutral lipid, a pH sensitive lipid, transferrin, biotin, a serum protein, a glycoprotein, polyethylene glycol, and a cationic lipid.

2. The composition of claim 1 , wherein said at least one nucleic acid agent comprises at least five nucleic acid agents, for down-regulating ATPase subunit A, RNA polymerase III, Inhibitor of apoptosis (IAP), FAS apoptotic inhibitor and α-Tubulin, each of said at least five nucleic acid agent targeting a different gene.

3. The composition of claim 1 , wherein said at least one nucleic acid agent comprises at least six nucleic acid agents, for down-regulating ATPase subunit A, RNA polymerase I, RNA polymerase III, Inhibitor of apoptosis (IAP), FAS apoptotic inhibitor and α-Tubulin, each of said at least six nucleic acid agents for targeting a different gene.

4. The composition of claim 2 , wherein said nucleic acid agents are as set forth in SEQ ID Nos: 1, 13, 27, 30 and 39.

5. The composition of claim 3 , wherein said nucleic acid agents are as set forth in SEQ ID Nos: 1, 4, 7, 10, 13, 16, 19, 22, 25, 27, 30, 33, 36 and 39.

6. The composition of claim 1 , wherein said composition is in solid form.

7. The composition of claim 1 , wherein said composition is in liquid form.

8. The composition of claim 1 , wherein said composition comprises protein.

9. The composition of claim 7 , wherein said liquid is a sucrose solution.

10. The composition of claim 7 , wherein said liquid is a corn syrup solution.

11. The composition of claim 7 , wherein said liquid further comprises a carbohydrate or sugar supplement.

12. The composition of claim 1 , wherein said nucleic acid sequence comprises a sequence complementary to at least 21 nucleotides of Varroa destructor mite messenger RNA (mRNA).

13. The composition of claim 12 , wherein said Varroa destructor mite mRNA encodes a polypeptide selected from the group consisting of ATPase subunit A, RNA polymerase III, IAP, FAS apoptotic inhibitor, and α-Tubulin.

14. The composition of claim 1 , wherein said nucleic acid sequence is greater than 15 base pairs in length.

15. The composition of claim 1 , wherein said nucleic acid sequence is greater than 19 to 25 base pairs in length.

16. The composition of claim 1 , wherein said nucleic acid sequence is greater than 30 base pairs in length.

17. The composition of claim 1 , wherein said at least one nucleic acid agent is selected from the group consisting of a double-stranded RNA (dsRNA), an antisense RNA, and a ribozyme.

18. The composition of claim 17 , wherein said dsRNA is selected from the group consisting of a small inhibitory RNA (siRNA), a short-hairpin RNA (shRNA), and a microRNA (miRNA).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2021
From: BEEOLOGICS, INC.
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 056799/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2017
From: SELA, ILAN; SHAFIR, SHARONI; MAORI, EYAL; GARBIAN, YAEL; KALEV, HAIM
To: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
Reel/Frame 043650/0523 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2017
From: BEN-CHANOCH, EYAL; YARDEN, GAL
To: BEEOLOGICS INC.
Reel/Frame 043650/0643 →
Continuity (5)
Continuation 14606328 · Jan 27, 2015
Continuation 13446557 · Apr 13, 2012
Continuation In Part PCTIL2010000844 · Oct 14, 2010
Provisional Application 61251339 · Oct 14, 2009
Related Publication 20170233743A1 · Aug 17, 2017